Only less than one fourth women with gestational diabetes receive type 2 diabetes screening: Study

Written By : Dr. Shravani Dali |Medically Reviewed By : Dr. Kamal Kant Kohli Published On 2022-04-15T09:45:08+05:30 | Updated On 15 April 2022 9:51 AM IST

Only less than one fourth women with gestational diabetes receive type 2 diabetes screening, according to a latest study published in the Primary Care Diabetes.

A study was conducted to estimate rates and identify determinants of post-partum glucose screening attendance in women with a history of gestational diabetes mellitus (GDM).

Retrospective cohort study using the Clinical Practice Research Datalink linked to Hospital Episode Statistics, to identify women diagnosed with GDM between 01/01/2000 and 05/11/2018. Age adjusted odds ratios (aOR) and 95% confidence intervals (CI) were estimated using multivariable logistic regression models.

The Results of the study are:

In 10,868 women with GDM, with an average follow-up of 5.38 years (95% CI 5.31,5.45), there was an average of 3.79 (95% CI 3.70,3.89) screening episodes per individual, with a mean time to first screening test of 1.22 (95% CI 1.18, 1.25) years.
South Asian women had a significantly greater likelihood of being screened compared to White women within the first 5 years post-partum, aOR: 1.89 95% CI (1.20,2.98).
A low proportion of women received at least one test per year of follow-up (23.87%).
Older age at GDM diagnosis, polycystic ovary syndrome, prescribed medication for GDM, and living in England, were all associated with a greater likelihood of being screened.

Thus, while the majority of women with previous GDM receive at least one glucose screening test within the first 5 years post-partum, fewer than a quarter of them receive on average one test per year of follow-up. Developing strategies to motivate more women to attend screening in primary care is essential.

Reference:

Screening for type 2 diabetes after a diagnosis of gestational diabetes by ethnicity: A retrospective cohort study by Elpida Vounzoulaki et al. published in the Primary Care Diabetes.

DOI: 10.1016/j.pcd.2022.03.008

Keywords:

Screening, type 2 diabetes, diagnosis, gestational diabetes, ethnicity, Elpida Vounzoulaki, Kamlesh Khunti, Joanne K Miksza, Bee K Tan, Melanie J Davies, Clare L Gillies, Primary Care Diabetes, Gestational diabetes mellitus; Primary health care; Screening; Type 2 diabetes mellitus; United Kingdom

Primary Care Diabetestype 2 diabetesScreeninggestational diabetes

Source : Primary Care Diabetes

Dr. Shravani Dali

Dr. Shravani Dali has completed her BDS from Pravara institute of medical sciences, loni. Following which she extensively worked in the healthcare sector for 2+ years. She has been actively involved in writing blogs in field of health and wellness. Currently she is pursuing her Masters of public health-health administration from Tata institute of social sciences. She can be contacted at editorial@medicaldialogues.in.

Dr. Kamal Kant Kohli

Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751